Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia

J Pediatr Hematol Oncol. 2009 Jan;31(1):79-80. doi: 10.1097/MPH.0b013e31818b37a9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Child
  • Child, Preschool
  • Down Syndrome / complications*
  • Down Syndrome / drug therapy*
  • Female
  • Guideline Adherence / statistics & numerical data*
  • Humans
  • Infant
  • Male
  • Mercaptopurine / administration & dosage
  • Methotrexate / administration & dosage
  • Neoplasm Recurrence, Local / diagnosis
  • Neoplasm Recurrence, Local / drug therapy
  • Patient Compliance / statistics & numerical data*
  • Physician's Role
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Randomized Controlled Trials as Topic
  • Survival Rate
  • Treatment Outcome

Substances

  • Mercaptopurine
  • Methotrexate